Canrib 100mg Tablet

Canrib 100mg tablet is a prescription based medication. It is used in the treatment of ovarian and breast cancer in adult patients. Its active ingredient is Olaparib and belongs to the class of PARP inhibitor. The medication works by targeting specific protein or pathways that help cancer cells grow. Strict doctor prescription is needed as the medication is not recommended to adult child under the age of 18. Proper medical supervision is essential while taking the medication to monitor effectiveness and manage any potential side effects.

Breast and ovarian cancer

• Muscle cramps
• Confusion, visual disturbances, seizures, and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High blood pressure
• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting, and diarrhea
• Mouth ulcers
• Constipation

Canrib 100mg tablet should be taken orally with a whole glass. The medication can be taken with or without food at the fixed time everyday, as directed by the healthcare professional. Do not crush or chew the tablet as this can affect the way the medicine is absorbed and reduce its effectiveness. Doctor Presrcription is still needed during the treatment as it should be used strictly under medical supervision.

Breast and ovarian cancer is caused by the mutation in DNA which turns healthy blood cells into abnormal cells. Canrib 100mg tablet contains PARP inhibitor which directly block the mutated gene and slow the progression of cancer cells in the body. The tablet helps prevent the tumor from growing and spreading to other parts of the body. By inhibiting PARP enzyme, it also prevent cancer cells from repairing damaged DNA, leading to cancer cell death.

• Gonzalez-Juarrero, M., Lukka, P. B., Wagh, S., Walz, A., Arab, J., Pearce, C., ... & Meibohm, B. (2021). Preclinical evaluation of inhalational spectinamide-1599 therapy against tuberculosis. ACS infectious diseases, 7(10), 2850-2863.
• Nasrollah, L., & Kiafar, C. (2015). An Unusual Case of Upper Gastrointestinal Bleeding: 542. Official journal of the American College of Gastroenterology| ACG, 110, S236-S237.
• Ali, M. Z., Dutt, T. S., MacNeill, A., Walz, A., Pearce, C., Lam, H., ... & Juarrero, M. G. (2024). A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides. Elife, 13, RP96190.
• Belardinelli, J. M., Verma, D., Li, W., Avanzi, C., Wiersma, C. J., Williams, J. T., ... & Jackson, M. (2022). Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus. Science translational medicine, 14(633), eabj3860.
• Greenblatt, R. B., Samaras, C., Vasquez, J. M., & Nezhat, C. (1982). Fibrocystic disease of the breast. Clinical Obstetrics and Gynecology, 25(2), 365-371.